QT Imaging Holdings, Inc. reported significant financial growth in its latest quarterly filing, with revenues reaching $4.2 million for the three months ended September 30, 2025, a 339% increase from $956,000 in the same period last year. For the nine months ending September 30, 2025, total revenue was $10.6 million, up 164% from $4.0 million in the prior year. The increase in revenue was primarily driven by the sale of nine QT Breast Scanners in the third quarter of 2025, compared to two sold in the same quarter of 2024, attributed to minimum order quantities established in the amended distribution agreement with NXC Imaging.
Despite the revenue growth, the company reported a net loss of $4.6 million for the third quarter, a 26% increase from a loss of $3.6 million in the same quarter of 2024. For the nine-month period, the net loss was $19.7 million, compared to $5.5 million in the previous year. The increase in losses was influenced by higher costs of revenue, which rose to $2.4 million in Q3 2025 from $351,000 in Q3 2024, reflecting the costs associated with increased scanner sales. Operating expenses also increased, with selling, general, and administrative expenses rising by 25% to $2.5 million in Q3 2025.
In terms of strategic developments, QT Imaging has made significant strides in expanding its market presence. The company entered into a Gulf Medical Distribution Agreement with Gulf Medical Co. to market and sell QT Breast Scanners in Saudi Arabia, with expected cash inflows of $11.2 million to $12.3 million in 2026. Additionally, the company has established a manufacturing agreement with Canon Medical Systems to support its production needs. These agreements are part of QT Imaging's broader strategy to enhance its distribution channels and increase product accessibility.
Operationally, QT Imaging has seen a notable increase in its customer base, with a total of 23 QT Breast Scanners sold in the first nine months of 2025, compared to nine in the same period of 2024. The company has also reported a significant increase in its cash position, with cash and restricted cash totaling $1.7 million as of September 30, 2025, up from $1.2 million at the end of 2024. This improvement in liquidity is attributed to financing activities, including a $10.1 million term loan from Lynrock Lake and proceeds from private placements.
Looking ahead, QT Imaging anticipates continued revenue growth driven by its distribution agreements and product sales. However, the company acknowledges the need for ongoing capital to support its operations and product development, with plans to raise additional funds through equity offerings and potential strategic partnerships. The management remains focused on achieving profitability while navigating the challenges associated with scaling its operations and expanding its market reach.
About QT IMAGING HOLDINGS, INC.
QT Imaging Holdings, Inc. develops innovative, non-invasive body imaging systems using ultra-low frequency sound waves. Its flagship product, the QT Breast Scanner, provides safe, radiation-free, high-resolution 3D images for breast cancer detection and diagnosis. The company aims to improve healthcare access, reduce costs, and enhance patient experience through portable, affordable imaging solutions for clinical, direct-to-consumer, and point-of-care markets worldwide.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.